Evidence map›Paper›PMID 42431913›Full record

ArticleScientific reports2026

Novel approach to early prediction of alzheimer's disease progression using integrated deep regulatory genetic neural network and optimized deep belief networks.

S Roobini, M S Kavitha, S Karthik

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S RoobiniDepartment of Computer Science and Engineering, SNS College of Technology, Coimbatore, Tamil Nadu, 641 035, India. srruby13@gmail.com.
M S KavithaDepartment of Computer Science and Engineering, SNS College of Technology, Coimbatore, Tamil Nadu, 641 035, India.
S KarthikDepartment of Computer Science and Engineering, SNS College of Technology, Coimbatore, Tamil Nadu, 641 035, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To enhance the prediction progression of Alzheimer's Disease is very excavating process. PROBLEM STATEMENT: It is often very difficult to implement in the chronic neurodegenerative disease-related preprocessed gene expression data. Especially, Alzheimer's Disease (AD) prediction is a very crucial process in AD metadata diagnosis. Novelty: To explore this challenging prediction process in brain disease prediction, this research presents a proposed deep learning model, namely the Integrated Deep Regulatory Genetic Neural Network and Optimised Deep Belief Networks (IDRODN). This integration increases the affluence of prediction progression from genomic data. These prediction systems help identify early AD.

methodThis research utilizes the IDRODN, which can predict and confine each network's neurons and hidden layers against the benchmark dataset of Alzheimer's gene expression and uncertainty to predict Alzheimer's Disease. KEY

resultsThe comparative analysis on data from the Alzheimer's disease gene expression data Initiative database has achieved an accuracy of 98.3%. In addition, it has achieved a high F1 score of 0.986 for predicting different stages from Gene expression data. IMPLICATIONS: This shows the most accurate technique for predicting Alzheimer's Disease (AD) using the prognostic IDRODN model.

Indexed as

Alzheimer DiseaseDeep LearningGene Regulatory NetworksNeural Networks, ComputerDisease ProgressionHumansPrediction AlgorithmsPredictive Learning ModelsAlzheimer’s diseaseComputational modellingConvolutional neural networksData modelsDeep learningDisease accuracyDisease progressionPredictive models

Identifiers

PMID42431913
PMCPMC13392091

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.